GLG LLC’s Dynavax Technologies DVAX Stock Holding History

GLG LLC’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-110,000	Closed	-$2.7M	–	556
2015 Q3	$2.7M	Buy	+110,000	New	+$3.11M	0.07%	258

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GLG LLC's DVAX Position: Q4 2015 in Review

GLG LLC sold out of Dynavax Technologies (DVAX) in Q4 2015, closing a stake of 110,000 shares — an estimated $2.7M sold.

GLG LLC first reported a position in DVAX in Q3 2015 and held it in 1 quarter. The position peaked at $2.7M in Q3 2015. 152 funds tracked by Wall St. Rank hold DVAX as of Q4 2015.

GLG LLC reported no remaining Dynavax Technologies position as of Q4 2015 after selling out during the quarter.
GLG LLC sold 110,000 Dynavax Technologies shares in Q4 2015, an estimated $2.7M.
GLG LLC first reported a position in Dynavax Technologies in Q3 2015 and held it in 1 quarter.
GLG LLC's Dynavax Technologies position peaked at $2.7M in Q3 2015.
152 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2015.

Based on GLG LLC's 13F filing for Q4 2015, filed 16 Feb 2016.